BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 26245695)

  • 21. Pyrrolidinone and pyrrolidine derivatives: Evaluation as inhibitors of InhA and Mycobacterium tuberculosis.
    Matviiuk T; Madacki J; Mori G; Orena BS; Menendez C; Kysil A; André-Barrès C; Rodriguez F; Korduláková J; Mallet-Ladeira S; Voitenko Z; Pasca MR; Lherbet C; Baltas M
    Eur J Med Chem; 2016 Nov; 123():462-475. PubMed ID: 27490025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and evaluation of C-5 modified 2'-deoxyuridine monophosphates as inhibitors of M. tuberculosis thymidylate synthase.
    Alexandrova LA; Chekhov VO; Shmalenyuk ER; Kochetkov SN; El-Asrar RA; Herdewijn P
    Bioorg Med Chem; 2015 Nov; 23(22):7131-7. PubMed ID: 26482569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular determinants of inactivation of the resuscitation promoting factor B from Mycobacterium tuberculosis.
    Ruggiero A; Marchant J; Squeglia F; Makarov V; De Simone A; Berisio R
    J Biomol Struct Dyn; 2013; 31(2):195-205. PubMed ID: 22831279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening of terpenes and derivatives for antimycobacterial activity; identification of geranylgeraniol and geranylgeranyl acetate as potent inhibitors of Mycobacterium tuberculosis in vitro.
    Vik A; James A; Gundersen LL
    Planta Med; 2007 Oct; 73(13):1410-2. PubMed ID: 17924309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative modeling and molecular docking study on Mycobacterium tuberculosis targets involved in peptidoglycan biosynthesis.
    Fakhar Z; Naiker S; Alves CN; Govender T; Maguire GE; Lameira J; Lamichhane G; Kruger HG; Honarparvar B
    J Biomol Struct Dyn; 2016 Nov; 34(11):2399-417. PubMed ID: 26612108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resisting resistant Mycobacterium tuberculosis naturally: mechanistic insights into the inhibition of the parasite's sole signal peptidase Leader peptidase B.
    Dhiman H; Dhanjal JK; Sharma S; Chacko S; Grover S; Grover A
    Biochem Biophys Res Commun; 2013 Apr; 433(4):552-7. PubMed ID: 23510997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potent Inhibitors of Acetyltransferase Eis Overcome Kanamycin Resistance in Mycobacterium tuberculosis.
    Willby MJ; Green KD; Gajadeera CS; Hou C; Tsodikov OV; Posey JE; Garneau-Tsodikova S
    ACS Chem Biol; 2016 Jun; 11(6):1639-46. PubMed ID: 27010218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimycobacterial activity of Citrullus colocynthis (L.) Schrad. against drug sensitive and drug resistant Mycobacterium tuberculosis and MOTT clinical isolates.
    Mehta A; Srivastva G; Kachhwaha S; Sharma M; Kothari SL
    J Ethnopharmacol; 2013 Aug; 149(1):195-200. PubMed ID: 23816500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel peptidomimetic peptide deformylase (PDF) inhibitors of Mycobacterium tuberculosis.
    Gokhale KM; Telvekar VN
    Chem Biol Drug Des; 2021 Jan; 97(1):148-156. PubMed ID: 32745362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In silico and in vitro Studies on Begomovirus Induced Andrographolide Biosynthesis Pathway in Andrographis Paniculata for Combating Inflammation and Cancer.
    Khan A; Sharma P; Khan F; Ajayakumar PV; Shanker K; Samad A
    Mol Inform; 2016 Jul; 35(6-7):253-61. PubMed ID: 27492239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ligand based virtual screening and biological evaluation of inhibitors of chorismate mutase (Rv1885c) from Mycobacterium tuberculosis H37Rv.
    Agrawal H; Kumar A; Bal NC; Siddiqi MI; Arora A
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3053-8. PubMed ID: 17418569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Probing the structure of Mycobacterium tuberculosis MbtA: model validation using molecular dynamics simulations and docking studies.
    Maganti L; Open Source Drug Discovery Consortium ; Ghoshal N
    J Biomol Struct Dyn; 2014; 32(2):273-88. PubMed ID: 23527569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and biological activities of triazole derivatives as inhibitors of InhA and antituberculosis agents.
    Menendez C; Gau S; Lherbet C; Rodriguez F; Inard C; Pasca MR; Baltas M
    Eur J Med Chem; 2011 Nov; 46(11):5524-31. PubMed ID: 21944473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, chemical synthesis of 3-(9H-fluoren-9-yl)pyrrolidine-2,5-dione derivatives and biological activity against enoyl-ACP reductase (InhA) and Mycobacterium tuberculosis.
    Matviiuk T; Rodriguez F; Saffon N; Mallet-Ladeira S; Gorichko M; de Jesus Lopes Ribeiro AL; Pasca MR; Lherbet C; Voitenko Z; Baltas M
    Eur J Med Chem; 2013; 70():37-48. PubMed ID: 24140915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Andrographis paniculata extracts and major constituent diterpenoids inhibit growth of intrahepatic cholangiocarcinoma cells by inducing cell cycle arrest and apoptosis.
    Suriyo T; Pholphana N; Rangkadilok N; Thiantanawat A; Watcharasit P; Satayavivad J
    Planta Med; 2014 May; 80(7):533-43. PubMed ID: 24782229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening of antitubercular compound library identifies novel shikimate kinase inhibitors of Mycobacterium tuberculosis.
    Rajput VS; Mehra R; Kumar S; Nargotra A; Singh PP; Khan IA
    Appl Microbiol Biotechnol; 2016 Jun; 100(12):5415-26. PubMed ID: 26887318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-based virtual screening as a tool for the identification of novel inhibitors against Mycobacterium tuberculosis 3-dehydroquinate dehydratase.
    Petersen GO; Saxena S; Renuka J; Soni V; Yogeeswari P; Santos DS; Bizarro CV; Sriram D
    J Mol Graph Model; 2015 Jul; 60():124-31. PubMed ID: 26043661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of pyrazolopyridones as a novel class of noncovalent DprE1 inhibitor with potent anti-mycobacterial activity.
    Panda M; Ramachandran S; Ramachandran V; Shirude PS; Humnabadkar V; Nagalapur K; Sharma S; Kaur P; Guptha S; Narayan A; Mahadevaswamy J; Ambady A; Hegde N; Rudrapatna SS; Hosagrahara VP; Sambandamurthy VK; Raichurkar A
    J Med Chem; 2014 Jun; 57(11):4761-71. PubMed ID: 24818517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A bioactive labdane diterpenoid from Curcuma amada and its semisynthetic analogues as antitubercular agents.
    Singh S; Kumar JK; Saikia D; Shanker K; Thakur JP; Negi AS; Banerjee S
    Eur J Med Chem; 2010 Sep; 45(9):4379-82. PubMed ID: 20584563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.